Skip to content
Cataract & Anterior Segment

Retrobulbar Anesthesia

Retrobulbar block is a technique of ophthalmic surgical anesthesia in which local anesthetic is injected into the intraconal space (retrobulbar space within the cone) behind the eye. It has the advantage of simultaneously achieving painlessness of the surgical field and akinesia of the eye.

Since Koller’s report of ophthalmic local anesthesia using cocaine in 1884, it has long been the gold standard for ophthalmic surgery. However, due to the invasiveness of the technique and the risk of complications, extraconal injection (peribulbar anesthesia, sub-Tenon’s anesthesia) is now positioned as the standard technique, and the use of retrobulbar block varies by facility and surgical procedure.

The incidence of serious systemic complications from ophthalmic local and regional anesthesia is reported to be 3.4 per 10,000, most of which are brainstem anesthesia, subarachnoid block, and convulsions due to spread of local anesthetic into the optic nerve sheath.

Comparison of Retrobulbar Block and Peribulbar Block

Section titled “Comparison of Retrobulbar Block and Peribulbar Block”

Retrobulbar Block

Injection site: Intraconal space

Quality of anesthesia: Strong and reliable painlessness and akinesia

Risk of globe perforation: Slightly higher

Risk of brainstem anesthesia: Possible due to optic nerve sheath puncture

Cochrane comparison: No difference in efficacy compared to peribulbar anesthesia

Peribulbar Anesthesia

Injection site: Extraconal space

Quality of anesthesia: Slightly weaker (supplemental injection may be needed)

Risk of globe perforation: Lower than retrobulbar

Chemosis: More common than retrobulbar

Eyelid hematoma: Less common than retrobulbar

Q Which is safer: retrobulbar anesthesia or general anesthesia?
A

In ophthalmic surgery, local anesthesia (retrobulbar/peribulbar) has the advantage of avoiding general anesthesia-related complications (e.g., aspiration, airway issues). However, retrobulbar anesthesia carries its own risk of serious complications such as brainstem anesthesia. The optimal method should be chosen in collaboration with an anesthesiologist, considering the patient’s overall condition, surgical procedure, and surgeon’s expertise.

Subjective Symptoms (During and After Procedure)

Section titled “Subjective Symptoms (During and After Procedure)”

Normal response when retrobulbar anesthesia is properly administered:

  • Disappearance of eye pain: Analgesia is achieved immediately after injection of the anesthetic agent
  • Sensation of eye fixation: Loss of eye movement due to extraocular muscle paralysis

Symptoms when complications occur:

  • Retrobulbar hemorrhage: Proptosis, hard eye, eyelid edema, rapid vision loss
  • Globe perforation: Sudden severe eye pain during or after injection, vitreous hemorrhage
  • Brainstem anesthesia: Sudden loss of consciousness, bilateral mydriasis, circulatory changes, central apnea 2–50 minutes after injection

Clinical findings (typical case of brainstem anesthesia)

Section titled “Clinical findings (typical case of brainstem anesthesia)”

In a case of a 91-year-old woman reported by Sanchez et al., the following findings appeared approximately 2 minutes after injection of 5 mL (2.5 mL of 1% ropivacaine + 2.5 mL of 2% lidocaine) for retrobulbar anesthesia. 1)

  • Sudden decrease in consciousness level (GCS 3)
  • Bilateral mydriasis with loss of light reflex
  • Sinus tachycardia (150 bpm), hypertension (225/100 mmHg)
  • Central apnea

BIS value 40–50 and EEG findings with delta wave predominance were observed. Head CT and blood tests were normal; the patient was extubated after 4 hours and discharged after 48 hours without neurological sequelae. 1)

In a case of a man in his 60s reported by Thomasius et al. (23G blunt needle 32 mm, mepivacaine 2% 2.5 mL + bupivacaine 0.5% 2.5 mL + hyaluronidase), hypertension (270/166 mmHg), tachycardia (130 bpm), and loss of spontaneous breathing occurred. Head CT showed intracranial emphysema and left frontal basal hematoma, confirming dural injury. After ICU management, vitrectomy was performed under general anesthesia the next day. 2)

In a case of a 72-year-old woman reported by Nanda et al. (31G blunt needle 25 mm, 0.5% bupivacaine 5 mL, for repair of globe rupture), a steady increase in ETCO2 and apnea appeared 7 minutes after injection, leading to a diagnosis of brainstem anesthesia. The patient was extubated after 1.5 hours and recovered. 3)

Risk Factors for Complications of Retrobulbar Anesthesia

Section titled “Risk Factors for Complications of Retrobulbar Anesthesia”

Operator-related factors

  • Inexperience of the operator: the greatest risk factor for complications
  • Needle length and size: 25G, maximum 25 mm is currently recommended. Longer needles increase the risk of optic nerve sheath puncture
  • Eye position during injection: The Atkinson method (“up and out” direction) endangers the optic nerve. Currently, primary gaze is recommended

Anatomical factors

  • Puncture of the optic nerve sheath: the main route by which local anesthetic spreads into the subarachnoid space and reaches the brainstem
  • Variation in ophthalmic artery course: In cases where the inferior branch of the ophthalmic artery lies below the optic nerve (about 15%), the risk of intra-arterial injection is high. In intra-arterial injection, local anesthetic flows retrograde into the internal carotid artery and reaches the midbrain, etc.
  • Axial length: In highly myopic (long axial length) eyes, the optic nerve sheath is elongated, increasing the risk of puncture

Drug and technique factors

  • Bupivacaine 0.75% alone: incidence of brainstem anesthesia is high at 1.5%. Mixed use with other drugs is recommended
  • Injection volume: keep small; appropriate volume is 2–4 mL
  • Performing under sedation: use of sedatives/analgesics masks early symptoms (pupillary dilation in the contralateral eye, agitation)

Patient-related factors

  • Elderly patients, severe obesity, and uncooperative patients tend to make puncture more difficult
Q How to differentiate brainstem anesthesia from intra-arterial injection?
A

In intra-arterial injection, a grand mal-like seizure typically appears as the first symptom within seconds to minutes after injection. In contrast, brainstem anesthesia presents with impaired consciousness, apnea, and circulatory changes 5 to 50 minutes (average 20.5 minutes) after injection. 3) The key differentiating point is that seizures are the main symptom in intra-arterial injection, whereas loss of consciousness and apnea are prominent in brainstem anesthesia.

Evaluation of Indications for Retrobulbar Anesthesia

Section titled “Evaluation of Indications for Retrobulbar Anesthesia”

The following should be evaluated before performing retrobulbar anesthesia:

  • Axial length: High myopia (long axial length) increases the risk of globe perforation and optic nerve sheath puncture
  • Medical history: Previous intraocular surgery or scleral buckling surgery may cause anatomical changes
  • Medication history: Check for anticoagulants and antiplatelet drugs (risk of retrobulbar hemorrhage). Dual antiplatelet therapy is associated with severe retrobulbar hemorrhage (reported occurrence in 2 of 3 cases with Grade IV retrobulbar hemorrhage)
  • General condition: ASA classification and need for sedation

If the following symptoms appear after retrobulbar anesthesia, brainstem anesthesia should be suspected first:

  • Sudden loss of consciousness or decrease in GCS
  • Bilateral mydriasis (including the contralateral eye)
  • Circulatory changes (tachycardia/hypertension or bradycardia/hypotension)
  • Loss of spontaneous breathing (central apnea)

Differential diagnoses: oversedation (excluded by minimal sedative use), stroke (excluded by imaging or complete recovery), intra-arterial injection (presence of seizures).

The incidence of central nervous system complications is reported to be 0.27–0.79%. In a study of 6,000 retrobulbar blocks, 16 cases (0.26%) of CNS signs and 1 case (0.02%) of cardiac arrest were identified. 2) The frequency of respiratory depression is reported to be approximately 0.03%. 2)

Basic Technique

  1. Place the patient in supine position with primary gaze.
  2. After skin disinfection, the puncture point is at the medial one-third of the lateral canthus (lower eyelid margin).
  3. Advance a 25G needle (maximum 25 mm) with bevel up, along the globe at a 10–15° angle posteriorly.
  4. After passing the equator of the globe, redirect 30–45° superonasally and advance another 2.5–3.5 cm.
  5. Aspirate to confirm no blood or CSF reflux, then inject the anesthetic.
  6. After injection, apply digital massage or a Honan balloon (30–35 mmHg) to promote diffusion and lower intraocular pressure.

Recommended Anesthetics

  • A mixture of 2% lidocaine and 0.75% bupivacaine is a common combination.
  • Some facilities add hyaluronidase (50 IU/mL) to enhance diffusion.
  • Injection volume: 2–4 mL (Sanchez case: 2.5 mL × 2 types = 5 mL) 1)
  • Use of bupivacaine 0.75% alone should be avoided due to high risk of brainstem anesthesia 3)

Precautions

  • The Atkinson method (upward and outward direction) is discontinued; injection with forward gaze is now standard
  • Intravenous cannulation is mandatory when using retrobulbar or peribulbar anesthesia and during intraoperative sedation
  • Performed by an experienced surgeon or under supervision

Treatment of brainstem anesthesia is primarily supportive, awaiting spontaneous recovery.

Acute management (ABCDE approach)

  • A (Airway): If loss of consciousness or apnea occurs, immediately start ventilation with a face mask
  • B (Breathing): Central apnea requires endotracheal intubation and mechanical ventilation
  • C (Circulation): Administer vasoactive drugs as needed for circulatory instability
  • D (Disability): Assess depth using BIS monitoring. Use propofol (low dose) to assist sedation during intubation
  • E (Exclude): Perform head CT and blood tests to rule out stroke or metabolic abnormalities

Prognosis for recovery

In most cases, symptoms completely resolve within a few hours as the anesthetic clears from the central nervous system. 1)2)3) For local anesthetic-induced central nervous system toxicity, lipid emulsion therapy (20% lipid emulsion: 1 mg/kg bolus followed by 15 mL/kg/h continuous infusion) is considered effective. 3)

The main mechanisms of brainstem anesthesia are broadly divided into the following two.

Mechanism 1: Optic nerve sheath puncture → spread into the subarachnoid space

The optic nerve is surrounded by three sheaths: dura mater, arachnoid mater, and pia mater. The subarachnoid space is continuous with the intracranial subarachnoid space. If the retrobulbar needle accidentally punctures the optic nerve sheath, the injected local anesthetic spreads via the subarachnoid space to the brainstem and diencephalon. Symptoms via this mechanism appear 5–50 minutes (mean 20.5 minutes) after injection. 3)

Mechanism 2: Intra-arterial injection → retrograde intracranial flow

In accidental injection into the ophthalmic artery, the local anesthetic flows retrogradely into the internal carotid artery and then to cerebral vessels, reaching the thalamus and midbrain. Symptoms via this mechanism appear within seconds to minutes, often with generalized convulsions resembling a grand mal seizure as the initial symptom.

Course of brainstem anesthesia

When local anesthetic reaches the brainstem, first, sympathetic hyperactivity due to parasympathetic blockade occurs (tachycardia, hypertension, bilateral mydriasis), followed by suppression of consciousness and respiratory centers, leading to coma and central apnea. As the local anesthetic is metabolized and redistributed, symptoms gradually resolve, and in most cases, all symptoms disappear within about 4 hours. 1)

When a head CT is performed for suspected brainstem anesthesia, abnormal findings are usually not observed. If there is dural injury (Thomasius case), intracranial emphysema may be confirmed. 2)

7. Latest Research and Future Prospects (Investigational Reports)

Section titled “7. Latest Research and Future Prospects (Investigational Reports)”

A method in which anesthetic is injected while confirming the needle tip position in real time using ultrasound (echo). Research is progressing as it may avoid accidental puncture of the optic nerve sheath or blood vessels. However, accurate understanding of intraorbital ultrasound anatomy and specialized equipment are required, and it is not yet standardized.

Sub-Tenon anesthesia, which has a much lower risk of globe perforation and optic nerve sheath puncture compared to retrobulbar and peribulbar anesthesia, is becoming more widespread as the first choice in many cataract and vitrectomy facilities. The frequency of retrobulbar anesthesia use is expected to decline further.

Case reports have accumulated that 20% lipid emulsion (1 mg/kg bolus → 15 mL/kg/h continuous) is life-saving for systemic toxicity of local anesthetics. 3) It is positioned as an adjunctive therapy when brainstem anesthesia becomes severe, but evidence for its efficacy against brainstem anesthesia (subarachnoid spread) is insufficient.


  1. Sanchez T, Rodrigues J. Brainstem anesthesia during retrobulbar block: an eye-opener clinical case. Cureus. 2024;16(8):e66294.
  2. Thomasius F, et al. Brainstem anesthesia after retrobulbar block under brief analgosedation: evidence from computed tomography. Eur J Ophthalmol. 2025. PMC12166138.
  3. Nanda S, et al. A case of brainstem anesthesia after retrobulbar block for globe rupture repair. Case Rep Anesthesiol. 2021. PMC8687828.

Copy the article text and paste it into your preferred AI assistant.